You Position: Home > Paper

M3 -R/IKM3--a new target of antiarrhythmic agents

( views:300, downloads:49 )
Author:
No author available
Journal Title:
ACTA PHARMACEUTICA SINICA
Issue:
1
DOI:
10.3321/j.issn:0513-4870.2005.01.002
Key Word:
心肌缺血;心律失常;M3受体,延迟整流电流;cardiac ischemia;arrhythmias;M3 receptor;delayed rectifier current

Abstract: Aim To investigate the relationship between M3-R/IKM3 and arrhythmia in order to find a new target for antiarrhythmic agents. Methods Using the acute ischemic model of rats and patch-clamp techniques, the effects of the M3 receptor on the occurrence of arrhythmias and its possible mechanisms were studied. Results In acute ischemic model of rats, the M3 receptor antagonist 4-diphenylacetoxy-N-methylpiperidine-methiodide (4DAMP) increased the occurrence of arrhythmias, and the M3 receptor agonist choline suppressed the onset and the development of arrhythmias (P < 0.01 ). No change was observed after treatment with other receptor antagonists (M1, M2, and M4 ). With patch-clamp techniques, it was found that choline induced K+ current could be inhibited by 4DAMP. Antagonists toward M1 , M2, and M4 receptors all failed to alter the current. Conclusion Choline modulates the cellular electrical properties of the heart, probably by activating a K + current via stimulation of the M3 receptor. M3-R/IKM3 may act as a new target for antiarrhythmic agents.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn